Delcath Systems

Yahoo Finance • 2 days ago

H.C. Wainwright Remains Bullish on Delcath Systems (DCTH)

Delcath Systems, Inc. (NASDAQ:DCTH) is one of the best medical device stocks to buy according to analysts. On August 6, H.C. Wainwright analyst Swayampakula Ramakanth maintained a bullish stance on Delcath Systems, Inc. (NASDAQ:DCTH), givi... Full story

Yahoo Finance • 9 days ago

Delcath outlines 175% projected HEPZATO volume growth and targets up to 28 operational centers by year-end 2025 amid expanding clinical pipeline

Earnings Call Insights: Delcath Systems (DCTH) Q2 2025 MANAGEMENT VIEW * Gerard J. Michel, CEO, highlighted, "Quarterly revenue reached $24.2 million, an increase of over 20% compared to the first quarter of 2025, reflecting continued... Full story

Yahoo Finance • 9 days ago

Delcath Systems GAAP EPS of $0.07 beats by $0.05, revenue of $24.2M beats by $1.18M

* Delcath Systems press release [https://seekingalpha.com/pr/20190883-delcath-systems-reports-second-quarter-2025-results-and-business-highlights] (NASDAQ:DCTH [https://seekingalpha.com/symbol/DCTH]): Q2 GAAP EPS of $0.07 beats by $0.05.... Full story

Yahoo Finance • 5 months ago

Beta Bionics Announces Board Appointment of Gerard Michel

IRVINE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced the appointment of Gerard Michel as an independent me... Full story

Yahoo Finance • 3 years ago

Delcath Systems Reports First Quarter 2022 Results and Provides Business Update

NEW YORK , May 10, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business highlights and financia... Full story

Yahoo Finance • 3 years ago

Delcath Systems to Participate in the Canaccord Genuity Horizons in Oncology Conference

NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, will participate in the Canaccord Genuity Hori... Full story

Yahoo Finance • 3 years ago

Delcath Systems to Participate in the Lytham Partners Spring 2022 Investor Conference

NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today that it will be participating... Full story

Yahoo Finance • 3 years ago

Delcath Systems Reports Fourth Quarter and Full-Year 2021 Results and Provides Business Update

NEW YORK, March 25, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business highlights and financi... Full story